Molecular and cellular effects of C-peptide--new perspectives on an old peptide.
John Wahren, Jawed Shafqat, Jan Johansson, Alexander Chibalin, Karin Ekberg, Hans Jörnvall
文献索引:Exp. Diabesity Res. 5 , 15-23, (2004)
全文:HTML全文
摘要
New results present C-peptide as a biologically active peptide hormone in its own right. Although C-peptide is formed from proinsulin and cosecreted with insulin, it is a separate entity with biochemical and physiological characteristics that differ from those of insulin. There is direct evidence of stereospecific binding of C-peptide to a cell surface receptor, which is different from those for insulin and other related hormones. The C-peptide binding site is most likely a G-protein-coupled receptor. The association constant for C-peptide binding is approximately 3 x 10(9) M(-1). Saturation of the binding occurs already at a concentration of about 1 nM, which explains why C-peptide effects are not observed in healthy subjects. Binding of C-peptide results in activation of Ca2+ and MAPK-dependent pathways and stimulation of Na+,K(+)-ATPase and eNOS activities. The latter 2 enzymes are both deficient in several tissues in type 1 diabetes. There is some evidence that C-peptide, and insulin may interact synergistically on the insulin signaling pathway. Clinical evidence suggests that replacement of C-peptide, together with regular insulin therapy, may be beneficial in patients with type 1 diabetes and serve to retard or prevent the development of long-term complications.
相关化合物
相关文献:
2010-08-01
[Diabetologia 53 , 1761-71 , (2010)]
1971-03-10
[J. Biol. Chem. 246 , 1375, (1971)]
2010-09-01
[FEBS J. 277 , 3759-3768, (2010)]
2010-01-01
[Biochem. Biophys. Res. Commun. 403 , 462-467, (2010)]
Intracellular signaling by C-peptide. Hills, C.E. and Brunskill, N.J.
[Exp. Diabetes Res. , 635158, (2008)]